Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Olanzapine Injection bulk supplier for pharma manufacturers

Olanzapine Injection Suppliers & Bulk Manufacturers

Available Forms: Depot Injection

Available Strengths: 210 mg, 300 mg, 405 mg per vial (monthly dosing)

Reference Brands: Zyprexa Relprevv (Depot Injection)

Category: Antipsychotropic Drugs

Olanzapine pamoate long-acting injection is a depot antipsychotic for schizophrenia, given every two or four weeks (210 to 405 mg). Patients must be observed for three hours after each injection because of a rare sedation and delirium reaction. The reference product is Zyprexa Relprevv. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Olanzapine Injection? List it or send an offer →

Product Description:

Olanzapine is an atypical antipsychotic used for schizophrenia and bipolar disorder management. Available in oral tablets, orally disintegrating tablets (ODT), and long-acting intramuscular injections, olanzapine is marketed under the brand Zyprexa and is available in strengths ranging from 2.5 mg to 20 mg for oral use. Depot injections such as Zyprexa Relprevv or Zypadhera offer long-term therapy. Pharma buyers seek bulk olanzapine for CNS therapeutic portfolios from GMP-certified manufacturers for global distribution.

Olanzapine Injection — third party manufacturing & bulk supply

Olanzapine Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Olanzapine Injection is supplied as Depot Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Olanzapine Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Olanzapine Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

A rare reaction with olanzapine pamoate where drug enters the bloodstream too fast, causing sedation, confusion or delirium; patients are observed for 3 hours after each injection.

210–405 mg every 2 or 4 weeks, depending on the previous oral dose.

As 210, 300 and 405 mg vials of powder with solvent, stored at room temperature.

Related Products

Olanzapine

Strength:
2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg

Form: Tablets/ODT

Reference Brands: Zyprexa, Zyprexa Zydis(US)

View Details
Naloxone

Strength:
0.4 mg/mL, 1 mg/mL in 1 mL ampoules or vials

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) Injection

Reference Brands: Narcan

View Details
Sertraline

Strength:
20 mg/mL

Form: Oral Solution

Reference Brands: Zoloft(US & EU)

View Details
Naloxone

Strength:
4 mg/0.1 mL

Form: Nasal Spray

Reference Brands: Narcan(US); Nyxoid (EU)

View Details
Paliperidone 6-Month IM Injection

Strength:
1,092 mg, 1,560 mg

Form: Once-6-Month IM Injection

Reference Brands: Invega Hafyera®(US)

View Details
Asenapine Sublingual Tablets

Strength:
5 mg, 10 mg

Form: Sublingual Tablets

Reference Brands: Saphris®(US); Sycrest® (EU)

View Details
Asenapine Transdermal Patch

Strength:
3.8 mg/24 hr, 5.7 mg/24 hr, 7.6 mg/24 hr

Form: Transdermal Patch

Reference Brands: Secuado®(US)

View Details
Lurasidone Tablets

Strength:
20 mg, 40 mg, 60 mg, 80 mg, 120 mg

Form: Oral Tablets

Reference Brands: Latuda (US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us